EKF Diagnostics Holdings plc EKF.L Stock
EKF Diagnostics Holdings plc Price Chart
EKF Diagnostics Holdings plc EKF.L Financial and Trading Overview
EKF Diagnostics Holdings plc stock price | 28.3 GBP |
Previous Close | 33.65 GBP |
Open | 32.7 GBP |
Bid | 32.1 GBP x 0 |
Ask | 34.3 GBP x 0 |
Day's Range | 32.7 - 34.06 GBP |
52 Week Range | 23.1 - 52.94 GBP |
Volume | 4.27K GBP |
Avg. Volume | 565K GBP |
Market Cap | 154.52M GBP |
Beta (5Y Monthly) | 0.747509 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0.01 GBP |
Forward Dividend & Yield | 0.01 (3.60%) |
Ex-Dividend Date | November 2, 2023 |
1y Target Est | 44.67 GBP |
EKF.L Valuation Measures
Enterprise Value | 139.45M GBP |
Trailing P/E | N/A |
Forward P/E | 0.18814918 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.318873 |
Price/Book (mrq) | 211.52174 |
Enterprise Value/Revenue | 2.093 |
Enterprise Value/EBITDA | 10.594 |
Trading Information
EKF Diagnostics Holdings plc Stock Price History
Beta (5Y Monthly) | 0.747509 |
52-Week Change | -2.39% |
S&P500 52-Week Change | 20.43% |
52 Week High | 52.94 GBP |
52 Week Low | 23.1 GBP |
50-Day Moving Average | 28.44 GBP |
200-Day Moving Average | 36.95 GBP |
EKF.L Share Statistics
Avg. Volume (3 month) | 565K GBP |
Avg. Daily Volume (10-Days) | 407.04K GBP |
Shares Outstanding | 453.73M |
Float | 387.11M |
Short Ratio | N/A |
% Held by Insiders | 5.45% |
% Held by Institutions | 61.98% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.012 |
Trailing Annual Dividend Yield | 0.035% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -15.15% |
Operating Margin (ttm) | 12.83% |
Gross Margin | 46.24% |
EBITDA Margin | 19.75% |
Management Effectiveness
Return on Assets (ttm) | 5.23% |
Return on Equity (ttm) | -11.31% |
Income Statement
Revenue (ttm) | 66.64M GBP |
Revenue Per Share (ttm) | 0.15 GBP |
Quarterly Revenue Growth (yoy) | -32.60% |
Gross Profit (ttm) | 30.81M GBP |
EBITDA | 13.16M GBP |
Net Income Avi to Common (ttm) | -10101000 GBP |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 11.58M GBP |
Total Cash Per Share (mrq) | 0.03 GBP |
Total Debt (mrq) | 1.55M GBP |
Total Debt/Equity (mrq) | 2.08 GBP |
Current Ratio (mrq) | 2.706 |
Book Value Per Share (mrq) | 0.161 |
Cash Flow Statement
Operating Cash Flow (ttm) | 9.69M GBP |
Levered Free Cash Flow (ttm) | 11.02M GBP |
Profile of EKF Diagnostics Holdings plc
Country | United Kingdom |
State | N/A |
City | Cardiff |
Address | Avon House |
ZIP | CF64 2EZ |
Phone | 44 29 2071 0570 |
Website | https://www.ekfdiagnostics.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 356 |
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls. Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-party businesses and laboratory services. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
Q&A For EKF Diagnostics Holdings plc Stock
What is a current EKF.L stock price?
EKF Diagnostics Holdings plc EKF.L stock price today per share is 28.3 GBP.
How to purchase EKF Diagnostics Holdings plc stock?
You can buy EKF.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EKF Diagnostics Holdings plc?
The stock symbol or ticker of EKF Diagnostics Holdings plc is EKF.L.
Which industry does the EKF Diagnostics Holdings plc company belong to?
The EKF Diagnostics Holdings plc industry is Medical Devices.
How many shares does EKF Diagnostics Holdings plc have in circulation?
The max supply of EKF Diagnostics Holdings plc shares is 4.54M.
What is EKF Diagnostics Holdings plc Price to Earnings Ratio (PE Ratio)?
EKF Diagnostics Holdings plc PE Ratio is 28.30000000 now.
What was EKF Diagnostics Holdings plc earnings per share over the trailing 12 months (TTM)?
EKF Diagnostics Holdings plc EPS is 0.01 GBP over the trailing 12 months.
Which sector does the EKF Diagnostics Holdings plc company belong to?
The EKF Diagnostics Holdings plc sector is Healthcare.
EKF Diagnostics Holdings plc EKF.L included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
FTSE AIM All-Share Index FTAI | 75.51 GBP 966.76 USD |
-0.02
|
1.06M GBP — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | 1.06M GBP — |
- {{ link.label }} {{link}}